ABVC 外匯新聞

Biopharmaceutical company ABVC BioPharma, Inc. (ABVC) announced Monday that it received a Taiwanese patent, Application No. 109130285, for the use of PDC-1421, a Radix Polygala (Polygala tenuifolia Willd) extract, which is used in the Company's asset ABV-1504 for the treatment of Major Depressive Disorder (MDD).